| Document |
Document Title |
|
WO/2022/096172A1 |
The present invention relates to compounds of a formula (I) or (II), processes for preparing compounds of this type, electronic devices containing one or more of these compounds, and the use of these compounds in electronic devices.
|
|
WO/2022/089408A1 |
A novel tetrahydronaphthalene compound, a stereoisomer, solvate, or pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the compound, and a use of the compound or the composition in the prevention and/or tre...
|
|
WO/2022/092260A1 |
The present invention addresses the problem of providing a cross-coupling reaction method that can use a wide variety of compounds as starting materials, that can substantially not use organic solvent, and that can rapidly provide reacti...
|
|
WO/2022/088917A1 |
A liquid crystal composition, specifically a nematic liquid crystal composition, and more specifically a liquid crystal composition containing terphenyl and containing cycloalkyl at the terminus, and an application thereof. The liquid cr...
|
|
WO/2022/089514A1 |
A polycyclic bioregulator, a preparation method therefor and an application thereof. In particular, the present invention relates to a compound represented by general formula (II) or a stereoisomer thereof, a preparation method therefor,...
|
|
WO/2022/089428A1 |
The present application relates to the technical field of organic materials, and provides a nitrogen-containing compound, an electronic element and an electronic device. The structure of the nitrogen-containing compound is as shown in fo...
|
|
WO/2022/085023A1 |
Functionalized benzocycloheptenes are one of the most important classes of bicyclic framework that have been investigated in different areas of biological activities. The claimed invention provides preparations of benzocycloheptene analo...
|
|
WO/2022/085762A1 |
The present invention addresses the problem of providing: a reagent that is for measuring skin sensitization and by which sensitization to a test substance can be measured with high sensitivity using a single reagent; a compound; and a m...
|
|
WO/2022/084168A1 |
The present invention relates to 4,6-difluorodibenzothiophene derivatives of formulae I-1 and I-2, to a process for the preparation thereof, to liquid-crystalline (LC) media comprising these derivatives and to electro-optical devices and...
|
|
WO/2022/082148A1 |
Processes and systems for producing isomeric mixtures of aromatic amine monomers from aromatic feeds. An example process for producing isomeric mixtures of aromatic amine monomers from aromatic feeds may include nitrating at least a port...
|
|
WO/2022/080715A1 |
The present invention provides a novel compound and an organic light-emitting device comprising same.
|
|
WO/2022/076383A1 |
The invention provides novel sulfonanilide and benzylsulfonyl derivatives, and compositions and methods of preparation and use thereof, that are useful in treating various diseases and disorders related to TRPML activities such as lysoso...
|
|
WO/2022/075746A1 |
The present invention provides: a novel compound capable of improving the light-emitting efficiency, stability, and lifespan of an element; an organic electrical element using same; and an electronic device thereof.
|
|
WO/2022/068292A1 |
The present application relates to an organic compound, and an electronic element and an electronic device using same. The structural formula of the organic compound is shown as formula 1. According to the organic compound provided in th...
|
|
WO/2022/068499A1 |
The present invention belongs to the technical field of liquid crystal materials, and specifically relates to a thiophene-containing liquid crystal compound, a preparation method therefor and the use thereof. The thiophene-containing liq...
|
|
WO/2022/065730A1 |
Provided is a cyano group-substituted aryl or heteroaryl derivative which effectively absorbs high-energy light in the UV region from an external light source to minimize damage to organic materials inside an organic electroluminescent d...
|
|
WO/2022/066774A1 |
This disclosure provides pharmaceutical compounds to treat medical disorders, such as complement-mediated disorders, including complement C1-mediated disorders.
|
|
WO/2022/065745A1 |
The present specification relates to a compound represented by chemical formula 1 and an organic light-emitting device including same.
|
|
WO/2022/052047A1 |
Provided are a microbicide and a sterilization method, wherein the microbicide contains a compound represented by chemical formula (I), wherein Ar1 and Ar2 are each independently a substituent-substituted or unsubstituted phenyl, naphthy...
|
|
WO/2022/048679A1 |
Disclosed are a thiophene structure-containing oxime ester photoinitiator, a preparation method therefor, and a photosensitive resin composition containing the photoinitiator and capable of serving as an alkaline photographic developer. ...
|
|
WO/2022/048922A1 |
The present invention relates to a compound of the following formula (I) or (II), optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph, cocrystal, tautomer, racemate, enantiomer, or diastereomer or mixture the...
|
|
WO/2022/051565A1 |
The invention provides substituted 4-piperidinyl-quinazolines, 4-piperidinyl-pyrimidine-2-amines, and related compounds, pharmaceutical compositions, their use for inhibiting ERK5 activity, and their use in the treatment of medical disor...
|
|
WO/2022/045231A1 |
This ester compound is represented by formula (1) [wherein R1 to R24 are each independently a hydrogen atom, a halogen atom, a hydrocarbon group, or a heteroatom-containing hydrocarbon group; R1 to R10, R23, and R24 may be bonded to each...
|
|
WO/2022/047148A1 |
Biologically silent small molecules that bind to RNA motifs but do not modify or negate the bioactivity of the RNA motif can be conjugated with an RNAase activator thereby degrading the RNA motif and negating its bioactivity.
|
|
WO/2022/043322A1 |
The present invention relates to compounds of formula (la) and the use thereof as inhibitors of P. aeruginosa virulence factor LasB. Formula (la). These compounds are useful in the treatment of bacterial infections, especially caused by ...
|
|
WO/2022/040747A1 |
The present invention relates to compounds that have zinc and/or iron ionophore activity and their use in treating diseases that are modulated by reducing zinc and/or iron. In particular embodiments, the compounds are compounds of formul...
|
|
WO/2020/249956A9 |
Compounds of general formula (I), which are useful for treating respiratory disease and other diseases and conditions modulated by TMEM16A. wherein A is defined as Formula.
|
|
WO/2022/045618A1 |
Provided is a tertiary amine derivative, which effectively absorbs high-energy external light source in a UV region to minimize damage to organic materials inside an organic electroluminescent device, and thus contributes to a substantia...
|
|
WO/2022/039520A1 |
The present invention provides a novel compound and an organic light-emitting device using same.
|
|
WO/2022/039340A1 |
The present specification relates to a heterocyclic compound represented by chemical formula 1 and an organic light-emitting device comprising same.
|
|
WO/2022/039563A1 |
The present application relates to a novel compound having inhibitory activity on prostaglandin E2 receptor and uses thereof, and provides a compound represented by formula I, a solvate, stereoisomer or pharmaceutically acceptable salt t...
|
|
WO/2022/038066A1 |
The present invention relates to compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices, containing these compounds.
|
|
WO/2022/033280A1 |
The present invention relates to an organic electroluminescent device and an electronic apparatus. The organic electroluminescent device comprises an anode, a hole transport layer, an organic light-emitting layer, an electron transport l...
|
|
WO/2022/032879A1 |
Provided is a photochemical synthesis method for a heteroaryl amine compound. The photochemical synthesis method comprises: step S1, mixing raw materials comprising a heteroaryl nitro compound, a solvent, and a photocatalyst to obtain a ...
|
|
WO/2022/032179A1 |
Disclosed herein are, inter alia, compounds modulating activity and methods of use thereof for treating PIN1 -mediated disorders.
|
|
WO/2022/028429A1 |
The present invention relates to use of a novel Arf1 inhibitor; a method for treating refractory, recurrent or metastatic cancer using these compounds; an investigate method for selectively killing cancer stem cells and cancer cells usin...
|
|
WO/2022/024928A1 |
The present invention addresses the problem of providing an actinic-ray-sensitive or radiation-sensitive resin composition capable of forming patterns having excellent LWR performance. Also provided are a resist film, a pattern formation...
|
|
WO/2022/025071A1 |
Provided is a compound represented by general formula (1). (In general formula (1), Ar1 and Ar2 independently represent groups selected from (AA), R1 to R6 represent hydrogen atoms, hydrocarbon groups, or heteroatom-containing hydrocarbo...
|
|
WO/2022/023929A1 |
Disclosed is a process for the production of erdosteine or the analogues and derivatives thereof which comprises reacting a solution of an activated derivative of thiodiglycolic acid with a solution of homocysteine thiol actone or a salt...
|
|
WO/2022/017975A1 |
Compounds of the formula (I) wherein the substituents are as defined in claim 1. Furthermore, the present invention relates to agrochemical compositions which comprise compounds of formula (I), to preparation of these compositions, and t...
|
|
WO/2022/020714A1 |
Described herein are HSD17B13 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of liver disease, metabolic disease, or cardiovascular disease, such...
|
|
WO/2022/017531A1 |
The present invention relates to a compound for treating thrombotic diseases. Specifically, the present invention provides a compound represented by formula I, or a pharmaceutically acceptable salt, or an enantiomer, or a diastereoisomer...
|
|
WO/2022/016898A1 |
The present application provides an organic compound, an organic electroluminescence device and an electronic apparatus. The chemical structure of the organic compound in the present application comprises an adamantane spirofluorene ring...
|
|
WO/2022/017997A1 |
The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds.
|
|
WO/2022/013417A1 |
Compounds of the formula (I), wherein the substituents are as defined in claim 1. Furthermore, the present invention relates to agrochemical compositions which comprise compounds of formula (I), to preparation of these compositions, and ...
|
|
WO/2022/013378A1 |
The present invention relates to compounds of general formula (I) inhibiting lysophosphatidic acid receptor 1 (LPA1), particularly the invention relates to compounds that are Ami do cyclohexane acid derivatives, methods of preparing such...
|
|
WO/2022/007909A1 |
The present application relates to the technical field of organic material and provides a nitrogen-containing compound, an electronic component and an electronic device. The nitrogen-containing compound has a structure as shown in formul...
|
|
WO/2022/010537A1 |
Provided herein are small molecules that bind to GAS41 and inhibit GAS41 activity, and methods of use thereof for the treatment of cancer.
|
|
WO/2022/002077A1 |
Disclosed in the present invention are an aryl aromatic heterocyclic derivative and preparation thereof and use thereof. The structure is as shown in formula I, and in this formula, the definitions of substituents are as stated in the de...
|
|
WO/2022/004473A1 |
The present invention provides: a photoelectric conversion element which has excellent photoelectric conversion efficiency with respect to blue to green light (specifically, light having a wavelength of from 400 nm to 550 nm), and which ...
|
